Heart-Healthy drugs may shield brain in At-Risk group
NCT ID NCT07447206
First seen Mar 08, 2026 · Last updated May 07, 2026 · Updated 8 times
Summary
This small pilot study will test whether a pharmacist-led program to manage high blood pressure and high cholesterol can help protect brain health in 10 people aged 50-75 who carry the APOE ε4 gene, a known risk factor for dementia. Participants will take standard medications (ARBs for blood pressure and statins for cholesterol) for six months. The goal is to see if this approach is feasible and improves blood pressure and cholesterol levels, which may lower dementia risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Sciences Building (CSC)
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.